State firms may not meet J&K drug need: Sources

A collapsed crusher machine on the banks of raging Tawi river in Jammu
Sushmi Dey New Delhi
Last Updated : Sep 18 2014 | 2:22 AM IST
Public-sector units (PSUs) may not be able to meet the demand for some essential medicines needed in the government's relief work at flood-hit Jammu & Kashmir (J&K), sources said. There have been reports from across the country of drug shortage in treating snake bites and malaria.

According to the health ministry, the J&K chief secretary has asked the Centre for 23 types of medicine. Of these, 14 have been supplied in full; six in part.

A PSU official said there was a lack of personnel, infrastructure and funds to cater to the need. More, the government would need to procure enough raw material or active pharmaceutical ingredients from outside through a tender to make formulations or finished products.

A source said, "The ministry has diverted the stocks to J&K. Additional orders for three medicines including paracetamol (used to reduce pain and fever) and oral rehydration solution pouches have been placed with a few PSUs. But the quantity is very less."

The major PSU makers are Indian Drugs & Pharmaceuticals (IDPL), Hindustan Antibiotics, Karnataka Antibiotics & Pharmaceuticals, Bengal Chemicals and Rajasthan Drugs & Pharmaceuticals. A source said these were making 130-140 medicines including antibiotics, vaccines used in government programmes and a few essential drugs. The consolidated annual turnover is estimated at Rs 500-550 crore compared with Rs 79,000 crore for the local formulation market.

IDPL has 200 employees in its three plants in Rishikesh, Gurgaon and Chennai. The production at Hindustan Antibiotics has almost come to a standstill due to its poor financial health, sources said. Karnataka Antibiotics, which has only one facility in the state, is one of the better, with Rs 250 crore annual turnover. But sources said most revenue was from 10-12 post-operative injections.

Amit Sengupta, co-convenor, Jan Swasthya Abhiyan, said, "Most are sick. There is little activity in the factories."

Antibiotics, malaria and snake venom drugs are needed in coastal regions, mainly during floods and monsoon. Sources said no state-run company was making those.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 18 2014 | 12:43 AM IST

Next Story